224 related articles for article (PubMed ID: 38102584)
1. Integrated bioinformatics and network pharmacology to explore the therapeutic target and molecular mechanisms of Bailing capsule on polycystic ovary syndrome.
Guan HR; Li B; Zhang ZH; Wu HS; He XL; Dong YJ; Su J; Lv GY; Chen SH
BMC Complement Med Ther; 2023 Dec; 23(1):458. PubMed ID: 38102584
[TBL] [Abstract][Full Text] [Related]
2. [
Gao M; Hong Y; Cui M; Huang J; Tan Y; Nie X
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jan; 42(1):1-12. PubMed ID: 35249865
[TBL] [Abstract][Full Text] [Related]
3. Liuwei Dihuang Pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K/Akt signaling pathway.
Qiu Z; Dong J; Xue C; Li X; Liu K; Liu B; Cheng J; Huang F
J Ethnopharmacol; 2020 Mar; 250():111965. PubMed ID: 31185267
[TBL] [Abstract][Full Text] [Related]
4. Investigating the active components of Huatan Tongjing decoction for the treatment of polycystic ovary syndrome via network pharmacology.
Yu J; Fu Y; Zeng L; Zheng Y
Chem Biol Drug Des; 2022 Oct; 100(4):515-524. PubMed ID: 35822313
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the mechanisms and experimental verification of Cuscuta-Salvia in the treatment of polycystic ovary syndrome (PCOS) via network pharmacology.
Zhang YY; Ma JX; Zhu YT; Wang YX; Chen WQ; Sun X; Zhang W; Wang CY; Ding CF
J Ovarian Res; 2022 Apr; 15(1):40. PubMed ID: 35379295
[TBL] [Abstract][Full Text] [Related]
6. Identification of Bioactive Compounds and Potential Mechanisms of Kuntai Capsule in the Treatment of Polycystic Ovary Syndrome by Integrating Network Pharmacology and Bioinformatics.
Li X; Ma J; Guo L; Dong C; Zhu G; Hong W; Chen C; Wang H; Wu X
Oxid Med Cell Longev; 2022; 2022():3145938. PubMed ID: 35528524
[TBL] [Abstract][Full Text] [Related]
7. The effective compounds and mechanisms of Cang-Fu-Dao-Tan Formula in treating polycystic ovary syndrome based on UPLC/Q-TOF-MS/MS, network pharmacology and molecular experiments.
Hu W; Xie N; Zhu H; Jiang Y; Ding S; Ye S; Zhang S; Wang F; Qu F; Zhou J
J Pharm Biomed Anal; 2024 Feb; 239():115867. PubMed ID: 38061171
[TBL] [Abstract][Full Text] [Related]
8. Exploring the efficacy and mechanism of Bailing capsule to improve polycystic ovary syndrome in mice based on intestinal-derived LPS-TLR4 pathway.
Guan HR; Li B; Zhang ZH; Wu HS; Wang N; Chen XF; Zhou CL; Bian XR; Li L; Xu WF; He XL; Dong YJ; Jiang NH; Su J; Lv GY; Chen SH
J Ethnopharmacol; 2024 Apr; 331():118274. PubMed ID: 38697410
[TBL] [Abstract][Full Text] [Related]
9. The mechanism of
Wu M; Liu H; Zhang J; Dai F; Gong Y; Cheng Y
J Pharm Pharm Sci; 2023; 26():11234. PubMed ID: 36942296
[No Abstract] [Full Text] [Related]
10. Curcumin Alleviates Hyperandrogenism and Promotes Follicular Proliferation in Polycystic Ovary Syndrome Rats: Insights on IRS1/PI3K/GLUT4 and PTEN Modulations.
Zheng L; Chen PF; Dai WC; Zheng ZQ; Wang HL
Chin J Integr Med; 2022 Dec; 28(12):1088-1095. PubMed ID: 36327049
[TBL] [Abstract][Full Text] [Related]
11. Network Pharmacology-Based Strategy for Predicting Active Ingredients and Potential Targets of
Ma JX; Ye M; Ma K; Zhou K; Zhang Y; Wang X; Tong H
Evid Based Complement Alternat Med; 2021; 2021():6651307. PubMed ID: 34457027
[TBL] [Abstract][Full Text] [Related]
12. Network pharmacology integrated with experimental validation reveals the regulatory mechanism of action of Hehuan Yin decoction in polycystic ovary syndrome with insulin resistance.
Wu YY; Li SY; Zhu HQ; Zhuang ZM; Shao M; Chen FL; Liu CS; Tang QF
J Ethnopharmacol; 2022 May; 289():115057. PubMed ID: 35121050
[TBL] [Abstract][Full Text] [Related]
13. Network pharmacology and experimental verification of the potential mechanism of Er-Xian decoction in aplastic anemia.
Ye M; Liu G; Yang Y; Yang H; Ren J; Chen W; Gao Z
Sci Rep; 2023 Oct; 13(1):17385. PubMed ID: 37833363
[TBL] [Abstract][Full Text] [Related]
14. Potential therapeutic drug targets and pathways prediction for premature ovarian insufficiency -Based on network pharmacologic method.
Ju S; He J; Wang H; Yang L; Guo A; Guo Y; Qi M; Wang H; Ai L
J Ethnopharmacol; 2023 Mar; 304():116054. PubMed ID: 36526095
[TBL] [Abstract][Full Text] [Related]
15. Integrating Bioinformatics and Network Pharmacology to Explore the Therapeutic Target and Molecular Mechanisms of Schisandrin on Hypertrophic Cardiomyopathy.
Shen C; Shen P; Wang X; Wang X; Shao W; Geng K; Xie H
Curr Comput Aided Drug Des; 2023; 19(3):192-201. PubMed ID: 36424782
[TBL] [Abstract][Full Text] [Related]
16. Exploring the molecular targets and mechanism of
Yu H; Zhang L; Yin F; Zhan C; Chen J; Chu J
Ann Transl Med; 2023 Feb; 11(3):149. PubMed ID: 36846000
[TBL] [Abstract][Full Text] [Related]
17. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
[TBL] [Abstract][Full Text] [Related]
18. Exploration of hub genes involved in PCOS using biological informatics methods.
Zhou F; Xing Y; Cheng T; Yang L; Ma H
Medicine (Baltimore); 2022 Oct; 101(40):e30905. PubMed ID: 36221354
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation.
Lu S; Sun X; Zhou Z; Tang H; Xiao R; Lv Q; Wang B; Qu J; Yu J; Sun F; Deng Z; Tian Y; Li C; Yang Z; Yang P; Rao B
Front Immunol; 2023; 14():1235575. PubMed ID: 37799727
[TBL] [Abstract][Full Text] [Related]
20. A network pharmacology study of mechanism and efficacy of Jiawei Huanglian-Wendan decoction in polycystic ovary syndrome with insulin resistance.
Shi N; Zhou Y; Ma H
Medicine (Baltimore); 2022 Dec; 101(48):e32057. PubMed ID: 36482532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
